Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Estimands and Estimates of Hospitalization Rates in Health Economics and Clinical Medicine.

Health economics·2026
Same author

What is the general Welfare: Welfare economic perspectives on equity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Erratum: Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose.

Epidemiology (Cambridge, Mass.)·2025
Same author

Novel approaches to optimization of drug dosages.

Clinical advances in hematology & oncology : H&O·2025
Same author

Comparing the cost of cirrhosis to other common chronic diseases: A longitudinal study in a large national insurance database.

Hepatology (Baltimore, Md.)·2025
Same author

Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose.

Epidemiology (Cambridge, Mass.)·2024

Related Experiment Video

Updated: Jul 4, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K

Navigating Uncertainty in Immunotherapy Regimens.

Charles F Manski1

  • 1Department of Economics and Institute for Policy Research, Northwestern University, Evanston, IL.

NEJM Evidence
|February 6, 2024
PubMed
Summary

Navigating immunotherapy regimens presents significant uncertainty for patients. This perspective highlights the need for improved evidence and methods to guide clinical decisions and enhance patient care.

Area of Science:

  • Oncology
  • Clinical Decision-Making
  • Health Services Research

Background:

  • Immunotherapy has revolutionized cancer treatment, offering new hope for patients.
  • However, treatment selection and management involve considerable uncertainty due to complex regimens and variable patient responses.
  • Patients often face challenges in understanding and navigating these treatment uncertainties.

Purpose of the Study:

  • To share a patient's lived experience with uncertainty in immunotherapy.
  • To discuss the academic perspective on improving evidence and methods for patient care.
  • To bridge the gap between clinical challenges and research aimed at better patient outcomes.

Main Methods:

  • Personal narrative from a patient and academic.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

363
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.1K

Related Experiment Videos

Last Updated: Jul 4, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

363
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.1K
  • Reflection on clinical experience and research endeavors.
  • Discussion of evidence-based practice and decision-making.

    • Main Results:

    • The abstract does not contain specific results but offers a perspective on navigating uncertainty.
    • Highlights the dual role of patient and researcher in understanding treatment challenges.
    • Emphasizes the need for enhanced data and methodologies in clinical practice.

    Conclusions:

    • Improved evidence and research methods are crucial for addressing uncertainty in immunotherapy.
    • Patient perspectives are vital in shaping research and clinical practice.
    • A patient-centered approach can lead to better navigation of complex cancer treatment regimens.